Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Price-to-sales ratio
3Y CAGR
-18.5%/yr
Annual compound
Percentile
P43
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.58 | -33.4% |
| 2024 | 11.38 | -66.6% |
| 2023 | 34.10 | +143.9% |
| 2022 | 13.98 | +72.4% |
| 2021 | 8.11 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |